- €278.06m
- €366.94m
- €203.56m
- 56
- 40
- 32
- 35
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 19.13 | ||
PEG Ratio (f) | 0.68 | ||
EPS Growth (f) | 39.12% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.44 | ||
Price to Tang. Book | 4.47 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.37 | ||
EV to EBITDA | 13.18 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.68% | ||
Return on Equity | 3.69% | ||
Operating Margin | 5.98% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 110.72 | 126.73 | 162.47 | 190.96 | 203.56 | 223.1 | 243 | 15.12% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +11.62 | -35.77 | +73.57 | -25.61 | -7.8 | +21 | +70.45 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Lumibird SA, formerly known as Societe Quantel SA, is a France-based company that is primarily engaged in the design, manufacture and sale of lasers. The Company offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The Company operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.
Directors
- Marc Le Flohic CHM
- Jean-Marc Gendre DCE
- Aude Nomblot-Gourhand CFO
- Pascal Guichard DHR
- Frederic Chiquet OTH
- Ajit Jayaratnam OTH
- Pierre Vallalta MGB
- Jean-Francois Coutris DRC
- Gwenaelle Le Flohic DRC
- Emmanuel Cueff IND
- Marie Begona Lebrun IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 19th, 1974
- Public Since
- September 30th, 1997
- No. of Employees
- 1,052
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 22,423,897
- Address
- 2 rue du Paul Sabatier, LANNION, 22300
- Web
- https://www.lumibird.com/
- Phone
- +33 169291700
- Contact
- Mathieu Calleux
- Auditors
- MAZARS
Upcoming Events for LBIRD
Half Year 2024 Lumibird SA Earnings Release
Q3 2024 Lumibird SA Corporate Sales Release
Similar to LBIRD
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
As of Today at 19:13 UTC, shares in Lumibird SA are trading at €12.40. This share price information is delayed by 15 minutes.
Shares in Lumibird SA last closed at €12.40 and the price had moved by -11.3% over the past 365 days. In terms of relative price strength the Lumibird SA share price has underperformed the FTSE Global All Cap Index by -18.74% over the past year.
The overall consensus recommendation for Lumibird SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Lumibird SA does not currently pay a dividend.
Lumibird SA does not currently pay a dividend.
Lumibird SA does not currently pay a dividend.
To buy shares in Lumibird SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €12.40, shares in Lumibird SA had a market capitalisation of €278.06m.
Here are the trading details for Lumibird SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: LBIRD
Based on an overall assessment of its quality, value and momentum Lumibird SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Lumibird SA is €17.90. That is 44.35% above the last closing price of €12.40.
Analysts covering Lumibird SA currently have a consensus Earnings Per Share (EPS) forecast of €0.53 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lumibird SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -22.53%.
As of the last closing price of €12.40, shares in Lumibird SA were trading -7.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Lumibird SA PE ratio based on its reported earnings over the past 12 months is 19.13. The shares last closed at €12.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Lumibird SA's management team is headed by:
- Marc Le Flohic - CHM
- Jean-Marc Gendre - DCE
- Aude Nomblot-Gourhand - CFO
- Pascal Guichard - DHR
- Frederic Chiquet - OTH
- Ajit Jayaratnam - OTH
- Pierre Vallalta - MGB
- Jean-Francois Coutris - DRC
- Gwenaelle Le Flohic - DRC
- Emmanuel Cueff - IND
- Marie Begona Lebrun - IND